Results 171 to 180 of about 309,962 (281)

Editorials: voices of a scientific journal. [PDF]

open access: yesCad Saude Publica
Alves LC, Lima LD, Carvalho MS.
europepmc   +1 more source

Criteris editorials

open access: yesIlles i Imperis, 1998

doaj  

Advances in Gastric Cancer Research: Insights Into Carcinogenesis, the Tumor Microenvironment, Metastasis, and Factors Influencing Prognosis

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ABSTRACT Background The Department of Gastroenterological Surgery at Kumamoto University has maintained a commitment to integrating cutting‐edge clinical practice with fundamental research, particularly concerning malignant diseases of the digestive tract.
Hideo Baba   +4 more
wiley   +1 more source

Pay It Forward, Please. [PDF]

open access: yesArthroplast Today
Levine BR.
europepmc   +1 more source

Editorial Editorial Editorial

open access: yesRevista da Escola de Enfermagem da USP, 2003
Maria Júlia Paes da Silva   +1 more
openaire   +1 more source

Short‐Term Outcomes of Robot‐Assisted Versus Laparoscopic Colectomy for Colon Cancer: A Propensity Score‐Matched Analysis

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This study compared short‐term outcomes of robot‐assisted versus laparoscopic colectomy for colon cancer using 1:1 propensity score matching. Among 218 matched pairs, robot‐assisted colectomy was associated with reduced blood loss, fewer conversions to open surgery, lower overall complication rates, and shorter hospital stays, despite longer operative ...
Akira Inoue   +9 more
wiley   +1 more source

Indian women in anaesthesia research: Touching the academic peaks. [PDF]

open access: yesIndian J Anaesth
Sripriya R   +3 more
europepmc   +1 more source

Essential Updates 2024–2025: Surgical Strategy for Esophageal Cancer Toward a New Paradigm in the Era of Immunotherapy and Personalization

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This review summarizes key advances from 2024 to 2025 that are reshaping esophageal cancer surgery toward a strategy‐oriented, personalized paradigm through the integration of immunotherapy, population aging, and intelligent technologies. Adjuvant nivolumab after neoadjuvant chemoradiotherapy remains the only perioperative approach with durable benefit,
Shuichiro Oya   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy